Center-Authored Papers

Filters: Keyword is Neutralization Tests  [Clear All Filters]
B
Blish CA, Sather ND, Sellhorn G, Stamatatos L, Sun Y, Srivastava I, Barnett SW, Cleveland B, Overbaugh J, Hu S-lok.  2010.  Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes.. Journal of virology. 84(5):2573-84. Abstract
Blish CA, Jalalian-Lechak Z, Rainwater S, Nguyen M-A, Dogan OC, Overbaugh J.  2009.  Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1.. Journal of virology. 83(15):7783-8. Abstract
C
Correia BE, Ban Y-EA, Holmes MA, Xu H, Ellingson K, Kraft Z, Carrico C, Boni E, Sather ND, Zenobia C et al..  2010.  Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope.. Structure (London, England : 1993). 18(9):1116-26. Abstract
Curlin ME, Huang M-L, Lu X, Celum CL, Sanchez J, Selke S, Baeten JM, Zuckerman RA, Erdman DD, Corey L.  2010.  Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men.. PloS one. 5(6):e11321. Abstract
G
Gilbert PB, Wang M, Wrin T, Petropoulos C, Gurwith M, Sinangil F, D'Souza P, Rodriguez-Chavez IR, DeCamp A, Giganti M et al..  2010.  Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.. The Journal of infectious diseases. 202(4):595-605. Abstract
Gray ES, Taylor N, Wycuff D, Moore PL, Tomaras GD, Wibmer CK, Puren A, DeCamp A, Gilbert PB, Wood B et al..  2009.  Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors.. Journal of virology. 83(17):8925-37. Abstract
H
Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD.  2000.  Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.. Journal of virology. 74(3):1524-32. Abstract
Halbert CL, Standaert TA, Wilson CB, Miller AD.  1998.  Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.. Journal of virology. 72(12):9795-805. Abstract
Hudachek SF, Kraft SL, Thamm DH, Bielefeldt-Ohmann H, DeMartini JC, Miller AD, Dernell WS.  2010.  Lung tumor development and spontaneous regression in lambs coinfected with Jaagsiekte sheep retrovirus and ovine lentivirus.. Veterinary pathology. 47(1):148-62. Abstract
K
Kong R, Louder MK, Wagh K, Bailer RT, DeCamp A, Greene K, Gao H, Taft JD, Gazumyan A, Liu C et al..  2015.  Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes.. Journal of virology. 89(5):2659-71. Abstract
Kraft Z, Strouss K, Sutton WF, Cleveland B, Tso FY, Polacino P, Overbaugh J, Hu S-lok, Stamatatos L.  2008.  Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.. Journal of virology. 82(12):5912-21. Abstract
P
Piantadosi A, Panteleeff D, Blish CA, Baeten JM, Jaoko W, McClelland SR, Overbaugh J.  2009.  Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.. Journal of virology. 83(19):10269-74. Abstract
R
Randhawa P, Viscidi R, Carter JJ, Galloway DA, Culp TD, Huang C, Ramaswami B, Christensen ND.  2009.  Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.. The Journal of general virology. 90(Pt 3):634-9. Abstract
S
Sather ND, Armann J, Ching LK, Mavrantoni A, Sellhorn G, Caldwell Z, Yu X, Wood B, Self SG, Kalams S et al..  2009.  Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.. Journal of virology. 83(2):757-69. Abstract
X
Xu H, Song L, Kim M, Holmes MA, Kraft Z, Sellhorn G, Reinherz EL, Stamatatos L, Strong RK.  2010.  Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity.. Journal of virology. 84(2):1076-88. Abstract